Anavex Life Sciences Corp (AVXL)

[GD]

PDD-001 time line:
PR on Jan 26, 2020 enrollment reached
14 WK trial end May 2020
Topline OCT 14, presentation NOV 6, 2020

PDD-001 OLE:
Let's assume all OLE qualified and willing patients enroll
in the OLE trail without disruption of taking 2-73 daily
and should be(IMO), the last patient enrolled into the OLE is
May 2020, following 48WK treatments, the OLE trail ends
in May 2021, than it is interesting which conference in
NOV (IF) AVXL wants to show case the PDD OLE data, and
PDD OLE data is 70% predictive of ALD trial outcome,
if the PDD OLE efficacy data is very strong, watch out!!!